Consolidated Financial Statement Detail |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2019 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Consolidated Financial Statement Detail | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Consolidated Financial Statement Detail |
3. Consolidated Financial Statement Detail Equity Securities As of December 31, 2019, equity securities consisted of an investment in Rezolute’s common stock of $0.7 million (see Note 4). The Company recognized a gain of $0.3 million due to the change in fair value of its investment in Rezolute’s common stock in other income, net line item of the consolidated statement of operations and comprehensive loss for the year ended December 31, 2019. Accrued and Other Liabilities Accrued and other liabilities consisted of the following (in thousands):
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||